Seven Eight Capital’s St Jude Medical STJ Stock Holding History

Seven Eight Capital’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-6,116	Closed	-$490K	–	765
2016 Q4	$490K	Sell	6,116 -8,900	-59%	-$706K	0.1%	294
2016 Q3	$1.2M	Buy	+15,016	New	+$1.21M	0.35%	99
2016 Q1	–	Sell	-6,606	Closed	-$408K	–	748
2015 Q4	$408K	Buy	+6,606	New	+$417K	0.28%	126
2015 Q3	–	Sell	-106	Closed	-$8K	–	750
2015 Q2	$8K	Sell	106 -100	-49%	-$7.22K	0.01%	460
2015 Q1	$13K	Buy	206 +200	+3,333%	+$13.3K	0.02%	382
2014 Q4	$0	Buy	+6	New	+$386	﹤0.01%	743
2014 Q1	–	Sell	-1,996	Closed	-$124K	–	601
2013 Q4	$124K	Buy	+1,996	New	+$116K	0.14%	231

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Seven Eight Capital's STJ Position: Q1 2017 in Review

Seven Eight Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 6,116 shares — an estimated $490K sold.

Seven Eight Capital first reported a position in STJ in Q4 2013 and held it in 7 quarters. The position peaked at $1.2M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

Seven Eight Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
Seven Eight Capital sold 6,116 St Jude Medical shares in Q1 2017, an estimated $490K.
Seven Eight Capital first reported a position in St Jude Medical in Q4 2013 and held it in 7 quarters.
Seven Eight Capital's St Jude Medical position peaked at $1.2M in Q3 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Seven Eight Capital's 13F filing for Q1 2017, filed 15 May 2017.